116 related articles for article (PubMed ID: 20686421)
1. Plasma glucose and not hemoglobin or renal function predicts mortality in patients with STEMI complicated with cardiogenic shock.
Vis MM; Engström AE; Sjauw KD; Tjong FV; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):827-31. PubMed ID: 20686421
[TBL] [Abstract][Full Text] [Related]
2. Patients with anemia on admission who have undergone primary angioplasty for ST elevation myocardial infarction: in-hospital and long-term clinical outcomes.
Ayhan E; Aycicek F; Uyarel H; Ergelen M; Cicek G; Gul M; Osmonov D; Yildirim E; Bozbay M; Ugur M; Işik T; Tezel T
Coron Artery Dis; 2011; 22(6):375-9. PubMed ID: 21558854
[TBL] [Abstract][Full Text] [Related]
3. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
[TBL] [Abstract][Full Text] [Related]
4. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of admission hemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock.
Vis MM; Sjauw KD; van der Schaaf RJ; Koch KT; Baan J; Tijssen JG; Piek JJ; de Winter RJ; Henriques JP
Am J Cardiol; 2007 May; 99(9):1201-2. PubMed ID: 17478141
[TBL] [Abstract][Full Text] [Related]
6. Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission.
Marenzi G; Assanelli E; Campodonico J; De Metrio M; Lauri G; Marana I; Moltrasio M; Rubino M; Veglia F; Montorsi P; Bartorelli AL
Crit Care Med; 2010 Feb; 38(2):438-44. PubMed ID: 19789449
[TBL] [Abstract][Full Text] [Related]
7. In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes.
Lazzeri C; Valente S; Chiostri M; Picariello C; Gensini GF
Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):419-23. PubMed ID: 20517158
[TBL] [Abstract][Full Text] [Related]
8. [Predictors of short term mortality in patients with acute ST-elevation myocardial infarction complicated by cardiogenic shock].
Liu Y; Zhu J; Tan HQ; Liang Y; Liu LS; Li Y;
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):695-701. PubMed ID: 21055135
[TBL] [Abstract][Full Text] [Related]
9. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction.
Brodie BR; Stuckey TD; Hansen C; Bradshaw BH; Downey WE; Pulsipher MW
Am J Cardiol; 2007 Feb; 99(4):431-5. PubMed ID: 17293178
[TBL] [Abstract][Full Text] [Related]
10. [Primary percutaneous coronary intervention in patients admitted with cardiogenic shock and ST-elevation myocardial infarction: prognosis and predictors of in-hospital mortality].
Ergelen M; Uyarel H; Akkaya E; Yıldırım E; Ersan D; Demirci D; Türkkan C; Sayar N; Akyüz S; Tezel T
Turk Kardiyol Dern Ars; 2010 Jun; 38(4):250-7. PubMed ID: 20935431
[TBL] [Abstract][Full Text] [Related]
11. Universal reperfusion therapy can be implemented: lessons from 20 years of management of patients admitted within 6 hours of symptom onset with ST-segment elevation acute myocardial infarction.
Juliard JM; Golmard JL; Ducrocq G; Himbert D; Aubry P; Garbarz E; Benamer H; Boudvillain O; Tchétché D; Feldman LJ; Burnod A; Greffet A; Lapostolle F; Steg PG
Arch Cardiovasc Dis; 2009 Apr; 102(4):259-67. PubMed ID: 19427603
[TBL] [Abstract][Full Text] [Related]
12. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
[TBL] [Abstract][Full Text] [Related]
13. Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction.
Greenberg G; Assali A; Vaknin-Assa H; Brosh D; Teplitsky I; Fuchs S; Battler A; Kornowski R; Lev EI
Am J Cardiol; 2010 Feb; 105(4):435-40. PubMed ID: 20152235
[TBL] [Abstract][Full Text] [Related]
14. Impact of initial 24-h urine output on short-term outcomes in patients with ST-segment elevation myocardial infarction admitted without cardiogenic shock and renal dysfunction.
Huang B; Yang Y; Zhu J; Liang Y; Tan H; Yu L; Gao X; Li J; Zhang H; Wang J; Wan H
Atherosclerosis; 2015 May; 240(1):137-43. PubMed ID: 25782166
[TBL] [Abstract][Full Text] [Related]
15. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
[TBL] [Abstract][Full Text] [Related]
16. Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention Trial.
Jarai R; Huber K; Bogaerts K; Sinnaeve PR; Ezekowitz J; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
Crit Care Med; 2010 Sep; 38(9):1793-801. PubMed ID: 20562693
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
[TBL] [Abstract][Full Text] [Related]
18. Gender disparity in 48-hour mortality is limited to emergency percutaneous coronary intervention for ST-elevation myocardial infarction.
Roncalli J; Elbaz M; Dumonteil N; Boudou N; Lairez O; Lhermusier T; Chilon T; Baixas C; Galinier M; Puel J; Fauvel JM; Carrié D; Ruidavets JB
Arch Cardiovasc Dis; 2010 May; 103(5):293-301. PubMed ID: 20619239
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.
Singh M; White J; Hasdai D; Hodgson PK; Berger PB; Topol EJ; Califf RM; Holmes DR
J Am Coll Cardiol; 2007 Oct; 50(18):1752-8. PubMed ID: 17964038
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction.
Osmancik P; Jirmar R; Hulikova K; Peroutka Z; Pompachova A; Motovska Z; Widimsky P
Catheter Cardiovasc Interv; 2010 Feb; 75(2):158-66. PubMed ID: 19902490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
